Cholangitis risk factors: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{FH}}
 
{{CMG}}; {{AE}} {{ADS}}, {{FH}}
{{Cholangitis}}
{{Cholangitis}}
==Overview==
==Overview==
Common risk factors in the development of cholangitis are [[gallstones]], [[sclerosing cholangitis]], and [[HIV]]. Variations in treatment and risk factors influence mortality rates in patients with cholangitis, and these rates underscore the necessity for standardized diagnostic, treatment, and severity assessment criteria.
The common [[risk factors]] in the development of cholangitis are dilatation of [[Common bile duct|common bile duct,]] [[CBD]] stones, [[gallstones]], [[sclerosing cholangitis]], and [[HIV]].  
 
==Risk factors==
==Risk Factors==
===Common risk factors===
Common risk factors for cholangitis include:<ref name="pmid2294844">{{cite journal |vauthors=Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J |title=Emergency surgery for severe acute cholangitis. The high-risk patients |journal=Ann. Surg. |volume=211 |issue=1 |pages=55–9 |year=1990 |pmid=2294844 |pmc=1357893 |doi= |url=}}</ref><ref name="pmid2930289">{{cite journal |vauthors=Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H |title=Acute cholangitis. Multivariate analysis of risk factors |journal=Ann. Surg. |volume=209 |issue=4 |pages=435–8 |year=1989 |pmid=2930289 |pmc=1493983 |doi= |url=}}</ref><ref name="pmidhttp://dx.doi.org/10.1148/rg.297095051">{{cite journal| author=Catalano O, Sahani DV, Forcione DG| title=Biliary Infections: Spectrum of Imaging Findings and Management. | journal=RadioGraphics | year= 2009 | volume= 29 | issue= 4 | pages= 2059-80 | pmid=http://dx.doi.org/10.1148/rg.297095051 | doi= | pmc= | url=http://pubs.rsna.org/doi/pdf/10.1148/rg.297095051}} </ref>
Common [[risk factors]] in the development of cholangitis include:<ref name="pmid2294844">{{cite journal |vauthors=Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J |title=Emergency surgery for severe acute cholangitis. The high-risk patients |journal=Ann. Surg. |volume=211 |issue=1 |pages=55–9 |year=1990 |pmid=2294844 |pmc=1357893 |doi= |url=}}</ref><ref name="pmid2930289">{{cite journal |vauthors=Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H |title=Acute cholangitis. Multivariate analysis of risk factors |journal=Ann. Surg. |volume=209 |issue=4 |pages=435–8 |year=1989 |pmid=2930289 |pmc=1493983 |doi= |url=}}</ref><ref name="CatalanoSahani2009">{{cite journal|last1=Catalano|first1=Onofrio A.|last2=Sahani|first2=Dushyant V.|last3=Forcione|first3=David G.|last4=Czermak|first4=Benedikt|last5=Liu|first5=Chang-Hsien|last6=Soricelli|first6=Andrea|last7=Arellano|first7=Ronald S.|last8=Muller|first8=Peter R.|last9=Hahn|first9=Peter F.|title=Biliary Infections: Spectrum of Imaging Findings and Management|journal=RadioGraphics|volume=29|issue=7|year=2009|pages=2059–2080|issn=0271-5333|doi=10.1148/rg.297095051}}</ref><ref name="YamamotoIshida2013">{{cite journal|last1=Yamamoto|first1=Ryuichi|last2=Ishida|first2=Shuko|last3=Osafune|first3=Yasuyo|last4=Takahashi|first4=Masatomo|last5=Harada|first5=Maiko|last6=Kato|first6=Shingo|last7=Nagoshi|first7=Sumiko|last8=Nishikawa|first8=Ko|last9=Yakabi|first9=Koji|title=Su1416 Risk Factors for Acute Cholangitis Caused by Common Bile Duct Stone: a Single-Center Study|journal=Gastrointestinal Endoscopy|volume=77|issue=5|year=2013|pages=AB316–AB317|issn=00165107|doi=10.1016/j.gie.2013.03.1069}}</ref>
*Advanced age (>70 years of age)
*Surgery of the [[biliary tract]]<ref name="pmid7716962">{{cite journal| author=Cybulski Z, Solarski J, Majewski W| title=[Infection as a risk factor in biliary system surgery]. | journal=Wiad Lek | year= 1994 | volume= 47 | issue= 15-16 | pages= 619-24 | pmid=7716962 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7716962  }} </ref>
*Neurologic disease
*Dilatation of [[common bile duct]] (CBD)
*Periampullary diverticula
*Previous history of [[gallstones]]
*Previous history of [[gallstones]]
*Large [[CBD]] stones
*A history of [[sclerosing cholangitis]]
*A history of [[sclerosing cholangitis]]
*Advanced age (>70 years of age)
* Procedure like [[ERCP]]<ref name="pmid1406012">{{cite journal| author=Sauter G, Ruckdeschel G, Sauerbruch T| title=[Antibiotic prevention and therapy of infectious complications in ERCP]. | journal=Leber Magen Darm | year= 1992 | volume= 22 | issue= 5 | pages= 173-6 | pmid=1406012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1406012  }} </ref>
===Less common risk factors===
Less common [[risk factors]] in the development of cholangitis include:<ref name="pmid2294844" /><ref name="pmid2930289" /><ref name="CatalanoSahani2009" /><ref name="YamamotoIshida2013" />
*[[HIV]]
*[[HIV]]
*[[Neurological|Neurologic]] disease
*Narrowing of the [[common bile duct]] due to cancer  
*Narrowing of the [[common bile duct]] due to cancer  
*Traveling to countries where you might catch a worm or parasite infection
*Traveling to countries where you might catch a worm or [[Parasites|parasite]] infection
*Presence of [[liver abscess]]  
*Presence of [[liver abscess]]  
*[[Acute renal failure]]
*[[Acute renal failure]]
*Periampullary [[Diverticular|diverticula]]


The [[bile]] of healthy individuals is generally [[aseptic]].<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>  
The [[bile]] of healthy individuals is generally [[aseptic]].<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>  
*Bile culture is positive for microorganisms in:  
*[[Bile]] culture is positive for [[microorganisms]] in:  
**16% of patients undergoing a non-biliary operation  
**16% of patients undergoing a non-biliary operation  
**72% of acute cholangitis patients
**72% of acute cholangitis patients
Line 25: Line 33:
**50% of patients with [[biliary obstruction]]
**50% of patients with [[biliary obstruction]]
*The [[bacteria]] in bile are identified in 90% of patients with [[choledocholithiasis]], accompanied by [[jaundice]].
*The [[bacteria]] in bile are identified in 90% of patients with [[choledocholithiasis]], accompanied by [[jaundice]].
*Patients with incomplete obstruction of the [[bile duct]] present with a higher positive bile culture rate than those with complete obstruction of the bile duct.<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>
*Patients with incomplete obstruction of the [[bile duct]] present with a higher positive [[bile]] culture rate than those with complete obstruction of the [[bile duct]].<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
 
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
[[Category:Infectious disease]]
{{WikiDoc Sources}}
[[Category:Surgery]]

Latest revision as of 20:55, 29 July 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Farwa Haideri [3]

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis risk factors

CDC on Cholangitis risk factors

Cholangitis risk factors in the news

Blogs on Cholangitis risk factors

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis risk factors

Overview

The common risk factors in the development of cholangitis are dilatation of common bile duct, CBD stones, gallstones, sclerosing cholangitis, and HIV.

Risk factors

Common risk factors

Common risk factors in the development of cholangitis include:[1][2][3][4]

Less common risk factors

Less common risk factors in the development of cholangitis include:[1][2][3][4]

The bile of healthy individuals is generally aseptic.[7]

References

  1. 1.0 1.1 Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann. Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  2. 2.0 2.1 Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H (1989). "Acute cholangitis. Multivariate analysis of risk factors". Ann. Surg. 209 (4): 435–8. PMC 1493983. PMID 2930289.
  3. 3.0 3.1 Catalano, Onofrio A.; Sahani, Dushyant V.; Forcione, David G.; Czermak, Benedikt; Liu, Chang-Hsien; Soricelli, Andrea; Arellano, Ronald S.; Muller, Peter R.; Hahn, Peter F. (2009). "Biliary Infections: Spectrum of Imaging Findings and Management". RadioGraphics. 29 (7): 2059–2080. doi:10.1148/rg.297095051. ISSN 0271-5333.
  4. 4.0 4.1 Yamamoto, Ryuichi; Ishida, Shuko; Osafune, Yasuyo; Takahashi, Masatomo; Harada, Maiko; Kato, Shingo; Nagoshi, Sumiko; Nishikawa, Ko; Yakabi, Koji (2013). "Su1416 Risk Factors for Acute Cholangitis Caused by Common Bile Duct Stone: a Single-Center Study". Gastrointestinal Endoscopy. 77 (5): AB316–AB317. doi:10.1016/j.gie.2013.03.1069. ISSN 0016-5107.
  5. Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.
  6. Sauter G, Ruckdeschel G, Sauerbruch T (1992). "[Antibiotic prevention and therapy of infectious complications in ERCP]". Leber Magen Darm. 22 (5): 173–6. PMID 1406012.
  7. 7.0 7.1 Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.


Template:WikiDoc Sources